SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-16-003952
Filing Date
2016-09-14
Accepted
2016-09-14 16:41:08
Documents
2
Period of Report
2016-09-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT e615405_4-nivalis.html 4  
1 OWNERSHIP DOCUMENT e615405_4-nivalis.xml 4 6741
2 e615405_ex99.htm EX-99 21582
  Complete submission text file 0001193805-16-003952.txt   30405
Mailing Address 780 THIRD AVENUE, 37TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017 2125511600
DEERFIELD MANAGEMENT CO (Reporting) CIK: 0001009258 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 161885457

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Reporting) CIK: 0001352546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 161885458

Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700
Nivalis Therapeutics, Inc. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations